BUY Dalmia Bharat Ltd. — Macquarie
byMacquarieHorizon: 1 year29 Jul 2026via Financial Express Market
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
10 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days
Advisor consensus · same horizon·12 Oct · 2w ago
Broker’s Call: Dalmia Bharat (Buy)
NewsHbl·28 Sept · 3w ago
Sugar Stocks Jump: Dalmia Bharat, Balrampur Chini, Shree Renuka & Others Surge Up To 13%
NewsNdtv-Profit·25 Sept · 4w ago
1 advisor has an active short-term BUY call on this stock
Advisor consensus · adjacent horizon·25 Sept · 4w ago
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·22 Oct · yesterday
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Dalmia Bharat
- BUY — Prakash Gaba16 Oct 2026 · ~2 weeks · target ₹1,750 · SL hit
- BUY — Emkay Global12 Oct 2026 · ~1 year · target ₹2,050 · Active
- BUY — HDFC Securities25 Sept 2026 · ~3 months · target ₹2,110 · Active
- BUY — Citigroup24 Sept 2026 · ~1 year · target ₹2,150 · Active
- BUY — Axis Securities2 Sept 2026 · ~1 year · target ₹2,260 · Active
More from Macquarie
- BUY The Indian Hotels Company22 Oct 2026 · ~1 year · target ₹860 · Active
- BUY Oil and Natural Gas Corporation15 Oct 2026 · ~1 year · target ₹260 · Active
- BUY Hitachi Energy India12 Oct 2026 · ~1 year · target ₹38,500 · Active
- BUY Titan Company7 Oct 2026 · ~1 year · target ₹5,600 · Active
- SELL Mankind Pharma7 Oct 2026 · ~1 year · target ₹2,200 · Active

